PerpEquities

Guardant Health, Inc. (GH) cash flow statement

NASDAQ · Healthcare · Medical - Diagnostics & Research · 2,498 employees · CEO Helmy Eltoukhy

Price
$145.83 +0.16%
Market cap
$19.7B
Enterprise value
$20.4B Data as of 2026-11-22
Last report
Q3 '26 filed 2026-11-05
Next report
2027-02-18 EPS est. -$0.75

In Q3 '26 Guardant Health, Inc. (GH) generated -$23.7M of operating cash flow, invested $13.5M in capital expenditure and kept -$37.2M of free cash flow. Over the last four quarters free cash flow was -$232M.

Cash flow

Cash flowTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Operating
Net income-$187M-$115M-$103M-$108M-$111M-$95.2M-$99.9M-$92.7M-$128M-$112M-$120M-$124M
Depreciation & amortization$10.9M$10.7M$10.6M$10.6M$10.5M$10.2M$10M$9.41M$10.1M$9.44M$9.56M$10.2M
Stock-based compensation$24.3M$27M$27.2M$49.8M$36.4M$37.8M$42.5M$42.8M$43.2M$47.6M$57.7M$62.4M
Change in working capital$64.2M$7.87M-$53.7M-$12.2M-$2.83M-$23.3M-$20.2M-$3.14M$32.3M-$23.3M-$14.3M$21M
Other non-cash items$8.96M$39.1M$24.5M$8.53M$2.51M$7.82M$7.35M$8.24M$16.6M$12.7M$9.34M$7.07M
Operating cash flow-$78.7M-$30.3M-$94M-$51.1M-$64.5M-$62.7M-$60.3M-$35.4M-$26.4M-$65.6M-$57.8M-$23.7M
Investing
Capital expenditure-$4.08M-$6.93M-$5.08M-$4.2M-$18.9M-$4.46M-$5.65M-$10.4M-$27.8M-$5.58M-$11.8M-$13.5M
Purchases of investments$0$0$0-$310M-$5M$0-$5M-$4M-$818M-$250M$0$0
Sales / maturities of investments$666M$35M$0$19.2M$34.4M$307M$0$0$0$955M$113M$0
Other investing$1.53M$0$0$0$0$0$0$0-$59M$0$0$0
Investing cash flow$663M$28.1M-$5.08M-$295M$10.5M$303M-$10.6M-$14.4M-$905M$699M$101M-$13.5M
Financing
Net debt issued / repaid$0$0-$181K$0$0$5.03M-$44K$44K$397M$0-$1.43M$0
Share buybacks$0$0$0$0$0-$45M$0$0$0$0$0$0
Other financing (incl. tax on vested shares)-$48K-$1.07M$6.08M-$2.89M-$2.94M-$26.9M-$7.57M$566K$315M-$25.2M-$3.84M-$4.34M
Financing cash flow$90.6M-$1.07M$5.9M-$2.89M-$2.94M-$66.9M$1.62M$4.33M$732M-$21.6M$23M$15M
Summary
FX effect on cash$1.03M-$1.14M-$837K$1.9M-$1.7M$773K$937K-$533K-$686K-$194K-$411K$440K
Net change in cash$676M-$4.43M-$94M-$347M-$58.6M$174M-$68.4M-$46M-$200M$612M$66.3M-$21.7M
Free cash flow (OCF - capex)-$82.8M-$37.2M-$99.1M-$55.3M-$83.4M-$67.1M-$65.9M-$45.8M-$54.2M-$71.2M-$69.5M-$37.2M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Operating cash flow, capex, free cash flow

quarterly

Uses of cash vs operating cash flow

fiscal years

Share count and EPS

quarterly, diluted

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30

Data as of 2026-11-22